Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Copernicus receives grant for PLASmin Complex project

Oct. 4, 2000

Telik awarded SBIR grant for new TRAP applications

Oct. 3, 2000

Bristol-Myers Squibb and Lexicon team up for high-throughput genetic target validation

Oct. 3, 2000

Potent adenosine transporter inhibitors synthesized by Kyowa Hakko useful as tools and leads

Oct. 2, 2000

Newly synthesized selective AMPA agonist used to elucidate receptor function

Oct. 2, 2000

Variagenics and Boehringer Ingelheim join forces for pharmacogenomics program

Sep. 29, 2000

Innovata and Vectura to develop inhaled protein and peptide drugs

Sep. 29, 2000

Sangamo and Rosetta to study new therapeutic agents

Sep. 28, 2000

Telik and Genaissance complete joint estrogen receptor research

Sep. 27, 2000

BPT and Pfizer join forces for pulmonary and systemic disease drug development

Sep. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...